Alnylam Pharmaceuticals shares owned by Royal London Asset Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Royal London Asset Management
from 13F filings
Historical chart of Royal London Asset Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Royal London Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Royal London Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $59M | 309k | 191.41 |
| 2023-09-30 | $54M | 307k | 177.12 |
| 2023-06-30 | $31M | 164k | 190.03 |
| 2023-03-31 | $25M | 125k | 200.32 |
| 2022-12-31 | $10M | 42k | 237.51 |
| 2022-09-30 | $8.1M | 41k | 200.04 |
| 2022-06-30 | $6.2M | 42k | 145.91 |
| 2022-03-31 | $6.8M | 42k | 163.33 |
| 2021-12-31 | $6.8M | 40k | 169.76 |
| 2021-09-30 | $7.8M | 41k | 188.93 |
| 2021-06-30 | $7.2M | 42k | 169.47 |
| 2021-03-31 | $6.0M | 42k | 141.23 |
| 2020-12-31 | $5.4M | 42k | 130.06 |
| 2020-09-30 | $6.2M | 43k | 145.00 |
| 2020-06-30 | $6.0M | 41k | 148.03 |
| 2020-03-31 | $4.4M | 41k | 108.82 |
| 2019-12-31 | $4.7M | 41k | 114.65 |
| 2019-09-30 | $3.2M | 40k | 80.39 |
| 2019-06-30 | $2.7M | 37k | 72.60 |
| 2019-03-31 | $3.4M | 36k | 93.49 |
| 2018-12-31 | $4.7M | 67k | 70.40 |
| 2018-09-30 | $5.0M | 57k | 87.53 |
| 2018-06-30 | $5.6M | 57k | 98.49 |
| 2016-06-30 | $3.9M | 70k | 55.48 |
| 2016-03-31 | $23k | 1.1M | 0.02 |
| 2015-12-31 | $6.6M | 70k | 94.54 |
| 2015-09-30 | $5.5M | 68k | 80.36 |
| 2014-12-31 | $27M | 28k | 970.04 |
| 2014-09-30 | $2.3M | 29k | 78.61 |
| 2014-06-30 | $1.6M | 29k | 57.29 |
| 2014-03-31 | $1.5M | 25k | 57.52 |
More positions owned by Royal London Asset Management
View all positions for Royal London Asset Management